Dr Reddys Laboratories Share Price Today - Live Blog for June 13, 2025

The share price of Dr Reddys Laboratories Ltd plunged by -0.02%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,362.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.06%. At this moment, it's actively trading at ₹1,363.45, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's share price rallied by 0.56%, reaching the current market price of ₹1,361.75. This surge is indicative of the stock's recent positive performance.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.29%, signalling a challenging period. Currently trading at ₹1,354.50, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price has dropped by -0.00%, a development that warrants careful analysis. Presently trading at ₹1,358.45, investors are assessing whether this presents an opportunity or a risk.

With a -0.08% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,358.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 20.1100, while the industry PE is 35.0103.

Dr Reddys Laboratories Ltd observed a -0.19% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,358.10. The stock has a PE ratio of 20.1100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a remarkable 0.01% surge in its share price and is presently trading at ₹1,360.15. The increased investor interest is driving this surge.

With a -0.01% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,361.05. This development raises questions about the factors behind the decline. The stock's PE ratio is 20.1100, while the industry PE is 35.0103.

Dr Reddys Laboratories Ltd's shares experienced a 0.14% uptick, and they are currently valued at ₹1,359.85, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd experienced a -0.06% downturn in its share price, and it's currently trading at ₹1,358.75. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd experienced a substantial 0.04% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,360.10, making it an appealing option for investors.

Dr Reddys Laboratories Ltd stock price decreased by -0.02%, with the current market value at ₹1,359.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Dr Reddys Laboratories Ltd experienced a -0.02% slump and is currently trading at ₹1,359.60. While the stock maintains a PE ratio of 20.1100, the industry PE is 35.0103, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd experienced a -0.02% slump and is currently trading at ₹1,359.60. While the stock maintains a PE ratio of 20.1100, the industry PE is 35.0103, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price rallied by 0.09%, reaching the current market price of ₹1,359.90. This surge is indicative of the stock's recent positive performance.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.09%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,359.90 per share.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.00% increase. Presently, it is actively trading at ₹1,358.65.

Dr Reddys Laboratories Ltd share price surged by 0.03%. With its current market price standing at ₹1,358.05 per share, this stock is garnering increased attention from the investment community.

After a -0.03% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,358.55. The stock has a PE ratio of 20.1100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.37%, a situation worth noting. At present, the stock is trading at ₹1,358.95. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 20.1100, while the industry PE ratio is 35.0103.

Dr Reddys Laboratories Ltd observed a remarkable 0.10% surge in its share price and is presently trading at ₹1,363.50. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.13% uptick in its share price. As a result, it's now actively trading at ₹1,360.15 per share, making it an attractive option for investors.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.13%, with its current market value per share resting at ₹1,360.15. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd shares saw a -0.18% decrease, reaching a current market price of ₹1,360.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 20.1100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Following a noteworthy 0.58% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,362.95. When it comes to valuation, this stock has a PE ratio of 20.1100, with the industry PE ratio at 35.0103.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.18%, reaching the current market price of ₹1,355.40. This development underscores the stock's growing popularity.

Demonstrating a commendable 0.33% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,354.45. In terms of valuation, the stock maintains a PE ratio of 20.1100, while the industry PE ratio stands at 35.0103.